Literature DB >> 8023317

HLA and disease associations: detecting the strongest association.

A Svejgaard1, L P Ryder.   

Abstract

A major aim of HLA and disease association studies is to identify the causative HLA factor truly responsible for the association. This is usually difficult due to the pronounced linkage disequilibrium between most HLA determinants. The causative factor must show the strongest association compared to all other factors. Here we describe a simple analysis which can be used to identify which of two factors, say A and B, shows the strongest association. The basic data for the analysis are the entries of the two-by-four table giving the four phenotypic combinations of A and B in patients and controls, respectively. These data are analyzed in various two-by-two tables involving stratification of each of the two factors against the other. A stronger increase of factor A is established if A is significantly associated with the condition both in B-positives and in B-negatives, when this is not true for B in A-positives and A-negatives. Using simulation with control data, it is demonstrated how linkage disequilibrium may influence secondary associations. The analysis may also be used to investigate interaction between HLA factors, but linkage disequilibrium complicates the interpretation in such cases. The method is exemplified using various published data. Finally, some statistical recommendations are given. Thus, we advise that phenotype (marker) frequencies are generally used instead of gene (i.e. allele, or haplotype) frequencies. The importance of correcting p-values, the levels of significance, and the power of Fisher's exact test are discussed.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8023317     DOI: 10.1111/j.1399-0039.1994.tb02291.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  66 in total

1.  Immunogenetic risk factors for anti-neutrophil cytoplasmic antibody (ANCA)-associated systemic vasculitis.

Authors:  M Gencik; S Borgmann; R Zahn; E Albert; T Sitter; J T Epplen; H Fricke
Journal:  Clin Exp Immunol       Date:  1999-08       Impact factor: 4.330

2.  HLA antigens in Omanis with blinding trachoma: markers for disease susceptibility and resistance.

Authors:  A G White; J Bogh; W Leheny; P Kuchipudi; M Varghese; H al Riyami; S al Hashmi; A S Daar
Journal:  Br J Ophthalmol       Date:  1997-06       Impact factor: 4.638

3.  Two critical genes (HLA-DRB1 and ABCF1)in the HLA region are associated with the susceptibility to autoimmune pancreatitis.

Authors:  Masao Ota; Yoshihiko Katsuyama; Hideaki Hamano; Takeji Umemura; Akinori Kimura; Kaname Yoshizawa; Kendo Kiyosawa; Hirofumi Fukushima; Seiamak Bahram; Hidetoshi Inoko; Shigeyuki Kawa
Journal:  Immunogenetics       Date:  2006-11-21       Impact factor: 2.846

4.  Immunogenetic profile of psoriasis vulgaris: association with haplotypes A2,B13,Cw6,DR7,DQA1*0201 and A1,B17,Cw6,DR7,DQA1*0201.

Authors:  I Ikaheimo; S Silvennoinen-Kassinen; J Karvonen; T Jarvinen; A Tiilikainen
Journal:  Arch Dermatol Res       Date:  1996-02       Impact factor: 3.017

5.  HLA class I and class II frequencies in patients with cutaneous malignant melanoma from southeastern Spain: the role of HLA-C in disease prognosis.

Authors:  José A Campillo; Jorge A Martínez-Escribano; Manuel Muro; Rosa Moya-Quiles; Luis A Marín; Olga Montes-Ares; Natalia Guerra; Paloma Sánchez-Pedreño; José F Frías; José A Lozano; Ana M García-Alonso; M Rocío Alvarez-López
Journal:  Immunogenetics       Date:  2005-12-20       Impact factor: 2.846

6.  Diseases associated with the major histocompatibility complex.

Authors:  S R Sloan
Journal:  West J Med       Date:  1997-07

7.  TNF microsatellite alleles in Brazilian Chagasic patients.

Authors:  Viriato Campelo; Roberto O Dantas; Renata T Simões; Celso T Mendes-Junior; Sandra M B Sousa; Aguinaldo L Simões; Eduardo A Donadi
Journal:  Dig Dis Sci       Date:  2007-08-23       Impact factor: 3.199

8.  Modulation of type 1 diabetes susceptibility by tumor necrosis factor alpha -308 G/A and lymphotoxin alpha +249 A/G haplotypes and lack of linkage disequilibrium with predisposing DQB1-DRB1 haplotypes in Bahraini patients.

Authors:  Mouna Stayoussef; Fayza A Al-Jenaidi; Abduljabbar Al-Abbasi; Khadija Al-Ola; Haya Khayyat; Touhami Mahjoub; Wassim Y Almawi
Journal:  Clin Vaccine Immunol       Date:  2007-11-07

9.  HLA class II profile and distribution of HLA-DRB1 and HLA-DQB1 alleles and haplotypes among Lebanese and Bahraini Arabs.

Authors:  Wassim Y Almawi; Marc Busson; Hala Tamim; Einas M Al-Harbi; Ramzi R Finan; Saria F Wakim-Ghorayeb; Ayesha A Motala
Journal:  Clin Diagn Lab Immunol       Date:  2004-07

10.  An increased risk of Crohn's disease in individuals who inherit the HLA class II DRB3*0301 allele.

Authors:  D G Forcione; B Sands; K J Isselbacher; A Rustgi; D K Podolsky; S Pillai
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-14       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.